The Development of an Oral Solution Containing Nirmatrelvir and Ritonavir and Assessment of Its Pharmacokinetics and Stability

• Main Authors: Lili Wang (Author), Zhuang Ding (Author), Zhengping Wang (Author), Yanna Zhao (Author), Hengqian Wu (Author), Qipeng Wei (Author), Lingfeng Gao (Author), Jun Han (Author)
• Format: Book
• Published: MDPI AG, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Paxlovid^®, a co-packaged medication comprised of separate tablets containing two active ingredients, nirmatrelvir (NRV) and ritonavir (RTV), exhibits good effectiveness against coronavirus disease 2019 (COVID-19). However, the size of the NRV/RTV tablets makes them difficult f...